Scrip Dividend Declaration

RNS Number : 2375C
Assura PLC
10 October 2022
 

10 October 2022

Assura plc

Scrip Dividend Declaration

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that, pursuant to its Scrip Dividend Scheme and in response to the scrip dividend alternative for the quarterly interim dividend payable on 12 October 2022 (the "Scrip Dividend Alternative"), elections were received in respect of 0.2 per cent. of the Company's ordinary shares in issue as at the record date of 9 October 2022.

Electing shareholders will receive ordinary shares in the Company ("Shares") in lieu of cash in respect of this dividend and, accordingly 52,001 Shares (the "New Shares") will be issued by the Company to such shareholders.

Application has therefore been made for the admission of the New Shares to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). The New Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 12 October 2022.

Following the allotment of the New Shares, it is expected that the total number of shares in issue will be 2,959,250,709 (none of which will be held in treasury) and that, accordingly, the total number of voting rights of the Company will be 2,959,250,709.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism ( https://data.fca.org.uk/#/nsm/nationalstoragemechanism ).

This interim dividend is 100% Property Income Distribution ("PID").

Forms to register for gross PIDs (on future interim dividends) are available on the Company's website. Please click here for PID Forms .

- ENDS -

For more information, please contact:

 

Assura plc
Orla Ball, Company Secretary
David Purcell, Investor Relations Director

Tel: 01925 945354
E mail: Investor@assura.co.uk

FGS Global
Gordon Simpson
James Thompson

Tel: 0207 251 3801
Email: Assura@fgsglobal.com

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which almost seven million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2022, Assura's portfolio was valued at £2,752 million.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

Assura plc LEI code: 21380026T19N2Y52XF72

*EPRA is a registered trademark of the European Public Real Estate Association.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVBUBDGRSGDGDR

Companies

Assura (AGR)
UK 100

Latest directors dealings